来自MSN1 个月
For IBD, No Cardiovascular Risk Difference Between JAK, TNF Inhibitors
ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors ...
Medpage Today on MSN4 个月
JAK Inhibitors Edge Out Anti-TNFs for Pain Relief in Rheumatoid Arthritis
For those staying on treatment for that long, achievement of "low pain" (scores less than 20 out of 100) was numerically ...